Change of safety interval from hyperviscosity problem in COVID-19 vaccine recipient with underlying diabetic problem

Guardado en:

Detalles Bibliográficos
Autores principales:	Pathum Sookaromdee, Viroj Wiwanitkit
Formato:	article
Lenguaje:	EN
Publicado:	Wolters Kluwer Medknow Publications 2021
Materias:	Diseases of the endocrine glands. Clinical endocrinology RC648-665 Diseases of the digestive system. Gastroenterology RC799-869
Acceso en línea:	https://doaj.org/article/16549c0c94e54b9b9db27c4710432494
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:16549c0c94e54b9b9db27c4710432494
record_format	dspace
spelling	oai:doaj.org-article:16549c0c94e54b9b9db27c47104324942021-11-12T10:10:56ZChange of safety interval from hyperviscosity problem in COVID-19 vaccine recipient with underlying diabetic problem2230-821010.4103/ijem.ijem_308_21https://doaj.org/article/16549c0c94e54b9b9db27c47104324942021-01-01T00:00:00Zhttp://www.ijem.in/article.asp?issn=2230-8210;year=2021;volume=25;issue=3;spage=257;epage=257;aulast=Sookaromdeehttps://doaj.org/toc/2230-8210Pathum SookaromdeeViroj WiwanitkitWolters Kluwer Medknow PublicationsarticleDiseases of the endocrine glands. Clinical endocrinologyRC648-665Diseases of the digestive system. GastroenterologyRC799-869ENIndian Journal of Endocrinology and Metabolism, Vol 25, Iss 3, Pp 257-257 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Diseases of the endocrine glands. Clinical endocrinology RC648-665 Diseases of the digestive system. Gastroenterology RC799-869
spellingShingle	Diseases of the endocrine glands. Clinical endocrinology RC648-665 Diseases of the digestive system. Gastroenterology RC799-869 Pathum Sookaromdee Viroj Wiwanitkit Change of safety interval from hyperviscosity problem in COVID-19 vaccine recipient with underlying diabetic problem
format	article
author	Pathum Sookaromdee Viroj Wiwanitkit
author_facet	Pathum Sookaromdee Viroj Wiwanitkit
author_sort	Pathum Sookaromdee
title	Change of safety interval from hyperviscosity problem in COVID-19 vaccine recipient with underlying diabetic problem
title_short	Change of safety interval from hyperviscosity problem in COVID-19 vaccine recipient with underlying diabetic problem
title_full	Change of safety interval from hyperviscosity problem in COVID-19 vaccine recipient with underlying diabetic problem
title_fullStr	Change of safety interval from hyperviscosity problem in COVID-19 vaccine recipient with underlying diabetic problem
title_full_unstemmed	Change of safety interval from hyperviscosity problem in COVID-19 vaccine recipient with underlying diabetic problem
title_sort	change of safety interval from hyperviscosity problem in covid-19 vaccine recipient with underlying diabetic problem
publisher	Wolters Kluwer Medknow Publications
publishDate	2021
url	https://doaj.org/article/16549c0c94e54b9b9db27c4710432494
work_keys_str_mv	AT pathumsookaromdee changeofsafetyintervalfromhyperviscosityproblemincovid19vaccinerecipientwithunderlyingdiabeticproblem AT virojwiwanitkit changeofsafetyintervalfromhyperviscosityproblemincovid19vaccinerecipientwithunderlyingdiabeticproblem
_version_	1718430973960388608

Change of safety interval from hyperviscosity problem in COVID-19 vaccine recipient with underlying diabetic problem

Ejemplares similares